IAG brings over 10 years of experience in advising on and delivering imaging critical clinical trials, where advanced imaging based biomarkers provide critical evidence of the novel compound safety and efficacy.
Our services are ISO13485 and 21 CFR part 11 complaint through the use of Quality Management System (QMS) with Standard Operating Procedures. (audited by clients and regulatory agencies). The QMS is audited on annual basis by British Standards Institute (BSI) and bi-annually by internal auditors, prompting continuous improvement of our processes and procedures.